We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0204 | 6.18181818182 | 0.33 | 0.355 | 0.3223 | 336409 | 0.33767426 | CS |
4 | -0.0808 | -18.7384044527 | 0.4312 | 0.46 | 0.304 | 1410218 | 0.33851049 | CS |
12 | -0.1096 | -23.8260869565 | 0.46 | 0.5323 | 0.304 | 935752 | 0.38256899 | CS |
26 | -0.0746 | -17.5529411765 | 0.425 | 0.6 | 0.25 | 913364 | 0.37907598 | CS |
52 | -0.6196 | -63.8762886598 | 0.97 | 1.09 | 0.25 | 682537 | 0.49786635 | CS |
156 | -9.4096 | -96.4098360656 | 9.76 | 17.82 | 0.25 | 544759 | 2.53840983 | CS |
260 | -9.5196 | -96.4498480243 | 9.87 | 17.82 | 0.25 | 512392 | 2.94692386 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions